Rohto Pharmaceutical Co.,Ltd.
RPHCF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $686,249 | $708,858 | $523,246 | $414,643 |
| - Cash | $77,161 | $89,210 | $585 | $582 |
| + Debt | $50,223 | $10,494 | $102 | $21,383 |
| Enterprise Value | $659,311 | $630,142 | $522,764 | $435,444 |
| Revenue | $308,625 | $270,840 | $238,664 | $199,646 |
| % Growth | 14% | 13.5% | 19.5% | – |
| Gross Profit | $174,939 | $157,286 | $1,017 | $937 |
| % Margin | 56.7% | 58.1% | 0.4% | 0.5% |
| EBITDA | $56,423 | $50,401 | $42,338 | $35,811 |
| % Margin | 18.3% | 18.6% | 17.7% | 17.9% |
| Net Income | $31,006 | $30,936 | $26,377 | $21,127 |
| % Margin | 10% | 11.4% | 11.1% | 10.6% |
| EPS Diluted | 135.44 | 135.21 | 115.29 | 92.34 |
| % Growth | 0.2% | 17.3% | 24.9% | – |
| Operating Cash Flow | $36,917 | $34,245 | $233 | $224 |
| Capital Expenditures | -$10,561 | -$8,912 | -$75 | -$93 |
| Free Cash Flow | $26,356 | $25,333 | $158 | $131 |